Article Versions Notes

Soltani S, Arabi A, Mann K, Hess A, Martinson HA, Kullberg M. C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences. Pharmaceutics. 2025; 17(4):468. https://doi.org/10.3390/pharmaceutics17040468

Soltani, Shahab, Ameneh Arabi, Kristine Mann, Austin Hess, Holly A. Martinson, and Max Kullberg. 2025. "C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences" Pharmaceutics 17, no. 4: 468. https://doi.org/10.3390/pharmaceutics17040468

Soltani, S., Arabi, A., Mann, K., Hess, A., Martinson, H. A., & Kullberg, M. (2025). C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences. Pharmaceutics, 17(4), 468. https://doi.org/10.3390/pharmaceutics17040468